KIM YONG CHAN enters BAUDAX BIO, INC. with 202.26K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/13/2023ACC: 0001062993-23-014868
202.26K
Baseline shares
100% direct
202.26K
Direct ownership
1 position
4.52M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned202.26K
Total
202.26K direct202.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 202.26K | Direct |
| Total | 202.26K | 202.26K direct |
Derivative Holdings1
Series X Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
4.52M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
4.52M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series X Preferred Stock Direct | Common Stock | — | — | 4.52M | N/A | |
| Total | 4.52M | 0.00 | ||||